tiprankstipranks
Trending News
More News >
Ascentage Pharma Group International Unsponsored ADR (AAPG)
NASDAQ:AAPG
US Market
AAPG
Ascentage Pharma Group International Unsponsored ADR
RESEARCH TOOLSreports

Ascentage Pharma Group International Unsponsored ADR (AAPG) Income Statement

Compare
6 Followers

Ascentage Pharma Group International Unsponsored ADR Income Statement

Last quarter (Q2 2024), Ascentage Pharma Group International Unsponsored ADR's total revenue was $―, a decrease of ― from previous quarter. In Q2, Ascentage Pharma Group International Unsponsored ADR's net income was $―. See Ascentage Pharma Group International Unsponsored ADR’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22
Total Revenue
$ ―$ ―
Gross Profit
$ 191.44M$ 193.86M
Operating Expenses
$ ―$ ―
Depreciation and Amortization
$ ―$ ―
EBITDA
$ -839.67M$ -817.56M
Operating Income
$ -896.50M$ -882.47M
Other Income/Expenses
$ ―$ ―
Pretax Income
$ ―$ ―
Net Income
$ -925.64M$ -876.22M
Per Share Metrics
Basic EPS
$ ―$ ―
Diluted EPS
$ ―$ ―
Weighted Average Shares Outstanding
Weighted Average Shares Outstanding (Diluted)
Currency in USD

Ascentage Pharma Group International Unsponsored ADR Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis